CLRB
USDCellectar Biosciences Inc. Common Stock
실시간 가격
가격 차트
핵심 지표
시장 지표
시가
$3.490
고가
$3.560
저가
$3.465
거래량
0.02M
기업 기본 정보
시가총액
11.2M
산업
생명공학
국가
United States
거래 통계
평균 거래량
0.19M
거래소
NCM
통화
USD
52주 범위
관련 뉴스
Cellectar Biosciences Receives Rare Pediatric Disease Designation from U.S. Food and Drug Administration for Iopofosine I 131 in Relapsed or Refractory Pediatric High-Grade Glioma
FLORHAM PARK, N.J., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ:CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of
Cellectar Biosciences Presented Promising Preclinical Data in Poster Presentation at the American Association for Cancer Research (AACR) Special Conference on Pancreatic Cancer Research
FLORHAM PARK, N.J., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ:CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of
Cellectar Biosciences, Inc. Enters Into Agreements to Raise $5.8 Million
FLORHAM PARK, N.J., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ:CLRB) ("Cellectar" or the "company"), a late-stage biotechnology company focused on the discovery and development of drugs for
